Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Evoke Pharma, Inc. (EVOK)

Pharmaceutical Preparations

https://www.evokepharma.com

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

420 STEVENS AVENUE, SUITE 370
SOLANA BEACH, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/25/2013

Market Cap

4,201,645

Shares Outstanding

3,340,000

Weighted SO

3,343,070

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

PTPI --.--%

CPIX --.--%

AGRX --.--%

PRFX --.--%

AQST --.--%

ADMP --.--%

GHSI --.--%

ACRX --.--%

EGRX --.--%

Beta

0.3710

Last Div

0.0000

Range

4.32-18.6

Chg

0.1378

Avg Vol

3630

Mkt Cap

4201645

Exch

NASDAQ

Country

US

Phone

858 345 1494

DCF Diff

0.8307

DCF

-0.1514

Div Yield

0.0000

P/S

0.5583

EV Multiple

-0.0039

P/FV

2.9255

Div Yield %

0.0000

P/E

-1.1942

PEG

-0.1150

Payout

0.0000

Current Ratio

1.2814

Quick Ratio

1.2239

Cash Ratio

0.9690

DSO

97.1465

DIO

872.3353

Op Cycle

969.4817

DPO

3497.0113

CCC

-2527.5295

Gross Margin

0.9697

Op Margin

-0.8260

Pretax Margin

-0.8675

Net Margin

-0.8675

Eff Tax Rate

0.5076

ROA

-0.5379

ROE

-9.6402

ROCE

-2.3325

NI/EBT

1.0000

EBT/EBIT

1.0502

EBIT/Rev

-0.8260

Debt Ratio

0.4120

D/E

1.8762

LT Debt/Cap

0.0000

Total Debt/Cap

0.6523

Int Coverage

-24.6617

CF/Debt

-1.1095

Equity Multi

4.5540

Rec Turnover

3.7572

Pay Turnover

0.1044

Inv Turnover

0.4184

FA Turnover

0.0000

Asset Turnover

0.6201

OCF/Share

-4.0686

FCF/Share

-4.0686

Cash/Share

6.7309

OCF/Sales

-0.7372

FCF/OCF

1.0000

CF Coverage

-1.1095

ST Coverage

-1.1095

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.9255

P/B

2.9255

P/S

0.5583

P/E

-1.1942

P/FCF

-0.7574

P/OCF

-1.4053

P/CF

-1.4053

PEG

-0.1150

P/S

0.5583

EV Multiple

-0.0039

P/FV

2.9255

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 14, 08:30 United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI GlobeNewswire Inc. Nov 09, 08:30 Evoke Pharma Reports Third Quarter 2023 Financial Results GlobeNewswire Inc. Oct 31, 08:30 Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023

Revenue Product Segmentation